-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S6ETU1ARV33QWMH1GA9YkXIdYo7f6ObK2hN1NqKRajsuBPX5mgEuTFZFnYiFkyMA ynb3sGjXi8UcjBCb0tJZWQ== 0001144204-07-036878.txt : 20070716 0001144204-07-036878.hdr.sgml : 20070716 20070716175838 ACCESSION NUMBER: 0001144204-07-036878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070713 FILED AS OF DATE: 20070716 DATE AS OF CHANGE: 20070716 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABEL DOUGLAS CENTRAL INDEX KEY: 0001324106 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 07982408 BUSINESS ADDRESS: BUSINESS PHONE: 2125829847 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 v081147_ex.xml X0202 4 2007-07-13 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHA 0001324106 ABEL DOUGLAS 810 SEVENTH AVENUE NEW YORK NY 10019 1 1 0 0 President and CEO Common Stock 2007-07-13 4 A 0 5000 0.34 A 35000 I IRA Account /s/ DOUGLAS ABEL 2007-07-16 -----END PRIVACY-ENHANCED MESSAGE-----